{
    "Trade/Device Name(s)": [
        "BioSign\u00ae Flu A+B",
        "Status Flu A & B"
    ],
    "Submitter Information": "Princeton BioMeditech Corporation",
    "510(k) Number": "K083746",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053146"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "November 8, 2010",
    "Summary Letter Received Date": "November 9, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A antigen",
        "Influenza B antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasopharyngeal aspirate/wash"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Rapid qualitative antigen detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for BioSign Flu A+B rapid immunochromatographic assay for detection of influenza A and B antigens from respiratory specimens",
    "Indications for Use Summary": "A rapid qualitative test for detection of influenza A and B antigens from nasal swab, nasopharyngeal swab, and aspirate/wash specimens to aid in the differential diagnosis of influenza viral infections in patients with respiratory symptoms; results are presumptive and intended for professional and laboratory use.",
    "fda_folder": "Microbiology"
}